Treatment of Hyperbilirubinemia Pharmacologic Approach SnMP(Tin-Mesoporphyrin)

This publication has 8 references indexed in Scilit:

• Control of Severe Hyperbilirubinemia in Full-term Newborns With the Inhibitor of Bilirubin Production Sn-Mesoporphyrin
  Pediatrics, 1999
• Control of Hyperbilirubinemia in Glucose-6-Phosphate Dehydrogenase-deficient Newborns Using an Inhibitor of Bilirubin Production, Sn-Mesoporphyrin
  Pediatrics, 1998
• Early Discharge From the Newborn Nursery—Effect on Scheduling of Follow-up Visits by Pediatricians
  Published by American Academy of Pediatrics (AAP) ,1997
• Sn-protoporphyrin lowers serum bilirubin levels, decreases biliary bilirubin output, enhances biliary heme excretion and potently inhibits hepatic heme oxygenase activity in normal human subjects
  Hepatology, 1988
• Reduction of the C2 and C4 vinyl groups of Sn-protoporphyrin to form Sn-mesoporphyrin markedly enhances the ability of the metalloporphyrin to inhibit in vivo heme catabolism
  Archives of Biochemistry and Biophysics, 1987
• Control of heme metabolism with synthetic metalloporphyrins.
  Journal of Clinical Investigation, 1986
• Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation.
  Proceedings of the National Academy of Sciences, 1981
• The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase.
  Proceedings of the National Academy of Sciences, 1968